According to Altamira Therapeutics's latest financial reports the company has $0.73 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.01 M | -98.45% |
2021-12-31 | $1.07 M | -91.57% |
2020-12-31 | $12.77 M | 793.37% |
2019-12-31 | $1.42 M | -73.93% |
2018-12-31 | $5.48 M | -64.34% |
2017-12-31 | $15.37 M | -51.71% |
2016-12-31 | $31.84 M | -37.37% |
2015-12-31 | $50.84 M | -11.71% |
2014-12-31 | $57.59 M | 114.1% |
2013-12-31 | $26.9 M | 38277.77% |
2012-12-31 | $0.07 M | -92.04% |
2011-12-31 | $0.88 M |